Senseonics Holdings, Inc. is a medical technology company which focused on the design, development and commercialization of glucose monitoring systems. Senseonics Holdings, Inc. is based in Germantown, United States.
Revenue (Most Recent Fiscal Year) | $22.39M |
Net Income (Most Recent Fiscal Year) | $-60.39M |
PE Ratio (Current Year Earnings Estimate) | -- |
PE Ratio (Trailing 12 Months) | -- |
PEG Ratio (Long Term Growth Estimate) | -- |
Price to Sales Ratio (Trailing 12 Months) | 9.88 |
Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 6.14 |
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
Pre-Tax Margin (Trailing 12 Months) | -269.73% |
Net Margin (Trailing 12 Months) | -270.13% |
Return on Equity (Trailing 12 Months) | -146.90% |
Return on Assets (Trailing 12 Months) | -49.81% |
Current Ratio (Most Recent Fiscal Quarter) | 7.53 |
Quick Ratio (Most Recent Fiscal Quarter) | 7.03 |
Debt to Common Equity (Most Recent Fiscal Quarter) | 1.15 |
Inventory Turnover (Trailing 12 Months) | 2.15 |
Book Value per Share (Most Recent Fiscal Quarter) | $0.07 |
Earnings per Share (Most Recent Fiscal Quarter) | $-0.03 |
Earnings per Share (Most Recent Fiscal Year) | $-0.11 |
Diluted Earnings per Share (Trailing 12 Months) | $-0.11 |
Exchange | NYSEMKT |
Sector | Healthcare |
Industry | Medical Devices |
Common Shares Outstanding | 530.82M |
Free Float | 513.83M |
Market Capitalization | $220.82M |
Average Volume (Last 20 Days) | 2.55M |
Beta (Past 60 Months) | 0.87 |
Percentage Held By Insiders (Latest Annual Proxy Report) | 3.20% |
Percentage Held By Institutions (Latest 13F Reports) | 12.36% |
Annual Dividend (Based on Last Quarter) | $0.00 |
Dividend Yield (Based on Last Quarter) | 0.00% |